abstract |
The present invention is mesenchymal stem cells; And it provides a pharmaceutical composition for the prevention or treatment of bone diseases, comprising one or more differentiation-inducing agent selected from the group consisting of fucoidan, suramin, and the compound of formula (NF157). In addition, the present invention is characterized in that differentiation of mesenchymal stem cells into osteoblasts using the suramin or the compound of formula 2 (NF157) as a differentiation inducing agent, osteoblasts, characterized in that differentiation of mesenchymal stem cells into osteoblasts. To provide. |